Wenjie Ma
Papers
2
Total Citations
57
H-Index
2
About
Dr. Wenjie Ma is a leading surgical oncologist specializing in the treatment of biliary tract malignancies, with a focused expertise in minimally invasive surgery (MIS) for complex hepatobiliary cancers. His research critically addresses the technical challenges of applying laparoscopic and robotic approaches to aggressive tumors like hilar cholangiocarcinoma (HCCA) and gallbladder carcinoma (GBC). In his seminal 2018 review on HCCA, cited 39 times, Dr. Ma delineated the anatomical barriers—such as extensive vascular and perineural invasion—that limit MIS, while outlining future strategies to expand its safe application. His 2020 work on GBC, with 18 citations, further explored the narrow therapeutic window for MIS in this highly invasive malignancy, emphasizing patient selection and oncologic principles. By systematically analyzing the current state and future perspectives of these procedures, Dr. Ma has provided a critical roadmap for surgeons, balancing the benefits of reduced morbidity against the risks of incomplete resection. His contributions are instrumental in advancing the field, offering clear guidance for integrating MIS into the management of some of the most challenging hepatobiliary cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2